Summary
This consensus document from leading international thoracic pathologists updates the WHO Classification of Lung Tumors to reflect six years of advances in molecular characterisation, diagnostic techniques, and clinical understanding since 2015. The classification serves as a standardised reference framework for pathologists and clinicians involved in lung cancer diagnosis and treatment planning. As a major international guideline, it consolidates emerging biomarkers and diagnostic criteria into formalised classification systems.
UK applicability
The updated WHO classification is directly applicable to UK pathology practice and lung cancer diagnosis, as it provides internationally harmonised diagnostic standards adopted by the National Health Service and UK cancer networks. UK pathologists and oncologists use WHO classifications as the primary reference for tumour reporting and multidisciplinary team discussions.
Key measures
Diagnostic algorithms, pathological classification categories, molecular biomarker integration, tumour histological subtypes
Outcomes reported
The study presents updated diagnostic criteria, molecular biomarkers, and classification algorithms for lung tumours as established by WHO consensus in 2021. It documents changes in pathological classification and incorporation of emerging molecular findings since the 2015 classification.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.